Ketamine use in sedation management in patients receiving extracorporeal membrane oxygenation

Intensive Care Medicine

Volumn 42, Issue 11, 2016, Pages 1822-1823

  Dzierba, Amy L ^a,c   Brodie, Daniel ^b   Bacchetta, Matthew ^c   Muir, Justin ^a   Wasson, Lauren ^a   Colabraro, Michael ^b   Gannon, Whitney ^b   Connolly, Kathleen ^b   Biscotti, Mauer ^c   Rietdijk, Wim ^d   Moitra, Vivek ^a   Bakker, Jan ^b,d  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c Department of Medicine   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; HYDROMORPHONE; KETAMINE; LORAZEPAM; MIDAZOLAM; OPIATE; ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANALGESIA; BREATHING RATE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP SEDATION; EXTRACORPOREAL OXYGENATION; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RICHMOND AGITATION SEDATION SCALE; SCORING SYSTEM; SEDATION; WAKEFULNESS; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; DOSE RESPONSE; RESPIRATORY DISTRESS SYNDROME, ADULT;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANESTHETICS, DISSOCIATIVE; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACORPOREAL MEMBRANE OXYGENATION; FENTANYL; HUMANS; HYDROMORPHONE; KETAMINE; MIDAZOLAM; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84987606970     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-016-4519-9     Document Type: Letter

References (5)

1. Shekar K, Roberts JA, Mullany DV, Corley A, Fisquet S, Bull TN et al (2012) Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure. Anaesth Intensive Care 40:648–655
2. Der Nigoghossian C, Dzierba AL, Etheridge J, Roberts R, Muir J, Brodie D et al (2016) Effect of extracorporeal membrane oxygenation use on sedative requirements in patients with severe acute respiratory distress syndrome. Pharmacotherapy 36:607–616
3. Timsit JF, Perner A, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Doig GS, Herridge M, Jaber S, Joannidis M, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Citerio G, Azoulay E (2015) Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics. Intensive Care Med 41(4):575–588. doi:10.1007/s00134-015-3755-8
4. Tellor B, Shin N, Graetz TJ, Avidan (2015) Ketamine infusion for patients receiving extracorporeal membrane oxygenation support: a case series. F1000Res 4:16
5. Dzierba AL, Bakker J, Muir J, Wasson L, Colabraro M, Gannon W, Connolly K, Brodie D (2015) Ketamine use for sedation management in patients receiving extracorporeal membrane oxygenation. Crit Care Med 43(12 Suppl 1):150